Cited by 124Vitamin C and Antioxidants ResearchComplementary and Alternative Medicine StudiesAntioxidant Activity and Oxidative Stress

Intravenous Vitamin C and Cancer: A Systematic Review

Open access
Fritz, Heidi, Flower, Gillian, Weeks, Laura, Cooley, Kieran, Callachan, Michael, McGowan, Jessie, Skidmore, Becky, Kirchner, Leesa +1 more·2014·Integrative Cancer Therapies

Abstract

Background. Intravenous vitamin C (IVC) is a contentious adjunctive cancer therapy, widely used in naturopathic and integrative oncology settings. We conducted a systematic review of human interventional and observational studies assessing IVC for use in cancer patients. Methods. We searched MEDLINE, EMBASE, The Cochrane Library, CINAHL, and AMED from inception to April 2013 for human studies examining the safety, effectiveness, or pharmacokinetics of IVC use in cancer patients. Results. Of 897 records, a total of 39 reports of 37 studies were included: 2 randomized controlled trials (RCTs), 15 uncontrolled trials, 6 observational studies, and 14 case reports. IVC dosing ranged from 1 g to more than 200 g ascorbic acid per infusion, typically administered 2 to 3 times weekly. IVC does not appear to increase toxicity or interfere with antitumor effects of gemcitabine/erlotinib therapy or paclitaxel and carboplatin. Based on 1 RCT and data from uncontrolled human trials, IVC may improve time to relapse and possibly enhance reductions in tumor mass and improve survival in combination with chemotherapy. IVC may improve quality of life, physical function, and toxicities associated with chemotherapy, including fatigue, nausea, insomnia, constipation, and depression. Case reports document several instances of tumor regression and long-term disease-free survival associated with use of IVC. Conclusion. There is limited high-quality clinical evidence on the safety and effectiveness of IVC. The existing evidence is preliminary and cannot be considered conclusive but is suggestive of a good safety profile and potentially important antitumor activity; however, more rigorous evidence is needed to conclusively demonstrate these effects. IVC may improve the quality of life and symptom severity of patients with cancer, and several cases of cancer remission have been reported. Well-designed, controlled studies of IVC therapy are needed.

Integrity signals

Registry

Crossref · 10.1177/1534735414534463

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A significant number of clinical trials have indicated that vitamin C administered intravenously in high-doses (in most trials, 50-100 g twice or thrice weekly) as a treatment for various cancers including glioblastoma, ovarian, prostate, lung, or rectum cancer is well tolerated with minimal toxicity, improves the quality of life for patients, and has a synergistic therapeutic effect when combined

    “A significant number of clinical trials have indicated that vitamin C administered intravenously in high-doses (in most trials, 50–100 g twice or thrice weekly) as a treatment for various cancers including glioblastoma, ovarian, prostate, lung, or rectum cancer is well tolerated with minimal toxicity, improves the quality of life for patients, and has a synergistic therapeutic effect when combined”
  • Most of these studies were not designed as large-scale randomized clinical trials and clear verifications of the clinical efficacy of vitamin C are currently rather limited.

    “However, most of these studies were not designed as large-scale randomized clinical trials and clear verifications of the clinical efficacy of vitamin C are currently rather limited [177,182,183,184].”
  • Vitamin C (ascorbic acid) is a powerful antioxidant that can have beneficial effects on delaying the aging process and age-related diseases through its action on redox oxidative and mitochondrial pathways, immune system, inflamm-aging, endothelial integrity, and lipoprotein metabolism.

    “Vitamin C or ascorbic acid (AA) is a powerful antioxidant that can have beneficial effects on delaying the aging process and age-related diseases thorough its action on redox oxidative and mitochondrial pathways, on the immune system, on inflamm-aging, on endothelial integrity, and on lipoprotein metabolism [114,115,116,117,118,119,120,121].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fritz, H., Flower, G., Weeks, L., Cooley, K., Callachan, M., McGowan, J., Skidmore, B., Kirchner, L., & Seely, D.
Affiliations
  • Canadian College of Naturopathic Medicine (CA)
  • Ottawa Integrative Cancer Centre, Ottawa, Ontario, Canada
  • Carp Ridge Natural Health Clinic, Carp, Ontario, Canada
Venue
Integrative Cancer Therapies
Published
2014-05-26
Volume
13
Issue
4
Pages
280-300
ISSN
  • 1534-7354 (ISSN-L)
  • 1552-695X
OpenAlex
W2100763849
Cited by
124
References
111
Citations by year
2026: 7 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 15 · 2021: 15 · 2020: 12 · 2019: 15 · 2018: 13 · 2017: 8 · 2016: 8 · 2015: 9 · 2014: 1 · 2013: 1
FWCI
8.07
Type
journal article
Language
en
Open access
Locations
  • Integrative Cancer Therapies (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
  • Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
Keywords
intravenous vitamin C, vitamin C, cancer therapy, adjunctive therapy, integrative oncology, naturopathy, chemotherapy toxicity, tumor regression, quality of life, safety profile, anticancer activity
MeSH terms
Antineoplastic Combined Chemotherapy Protocols, Ascorbic Acid, Humans, Infusions, Intravenous, Neoplasms, Quality of Life, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review